comparemela.com

Latest Breaking News On - Eton pharmaceuticals - Page 9 : comparemela.com

The Benchmark Company Announces Upcoming 12th Annual

Eton Pharmaceuticals (NASDAQ:ETON) Shares Up 4.5%

Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) shot up 4.5% during trading on Monday . The stock traded as high as $3.95 and last traded at $3.91. 87,825 shares changed hands during trading, a decline of 52% from the average session volume of 183,452 shares. The stock had previously closed at $3.74. […]

Nasdaq
Eton-pharmaceuticals
Blackrock-inc
Renaissance-technologies
Bailard-inc
Eton-pharmaceuticals-company-profile
Eton-pharmaceuticals-inc
Raymond-james-associates
Eton-pharmaceuticals-trading
News-ratings-for-eton-pharmaceuticals-daily
Hedge-funds-weigh-in-on-eton-pharmaceuticals

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

DEER PARK, Ill., Oct. 30, 2023 Eton Pharmaceuticals, Inc. , an innovative pharmaceutical company focused on developing, acquiring, and commercializing products to address unmet needs in patients.

Lisam-wilson
Eton-pharmaceuticals
Nasdaq
Eton-pharmaceuticals-inc
Site-communications-inc
Audio-only
Carglumic-acid
Betaine-anhydrous
In-site-communications
Markets

DelveInsight Business Research, LLP: The Evolving Market Dynamics of Rare Diseases: WHIM Syndrome, Adrenal Crisis, Molybdenum Cofactor Deficiency Type-A (MoCoD-A), and Necrotizing Enterocolitis

DelveInsight Business Research, LLP: The Evolving Market Dynamics of Rare Diseases: WHIM Syndrome, Adrenal Crisis, Molybdenum Cofactor Deficiency Type-A (MoCoD-A), and Necrotizing Enterocolitis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states
Abbvie-teneoone
Bristol-myers-squibb
Heidelberg-pharma
Roche-genentech
Indiens-wirtschaft
Shruti-thakur
Johnson-janssen
Theravance-biopharma
Gensight-biologics
Ihre-chancen
Holostem-terapie-avanzate

Harrow Health, Inc. (NASDAQ:HROW) Shares Sold by Mendota Financial Group LLC

Mendota Financial Group LLC lowered its holdings in shares of Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 4.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,073 shares of the company’s stock after selling 884 shares during the […]

Martina-makary
Markl-baum
Surface-ophthalmics-inc
Advisor-alliance
Mendota-financial-group
News-ratings-for-harrow-health-daily
Exchange-commission
Harrow-health-inc
Clarivest-asset-management
Silver-oak-securities-incorporated
Harrow-health-profile

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.